|
||||||||
![]() |
||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]()
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The vector sequence has been compiled using the information from sequence databases, published literature, and other sources, together with partial sequences obtained by Evrogen. This vector has not been completely sequenced. |
|||||||||||||||||||||||||||||||||||||||||||||||||
![]() Download
|
| ||||||||||||||||||||||||||||||||||||||||||||||||
| PhiYFP-m | Sac I | EcoR I | Sal I | Kpn I | Apa I | BamH I | Stops | |||||||||||||||||||||
| Xho I | Hind III | Pst I | Sac II* | Xba I# | Bcl I# | |||||||||||||||||||||||
| ACC.TAC.CTG. | GGA.T | CT.C | GA.G | CT.C | AA.GCT.T | C | G.AAT.T | C | T.GCA. | G | TC.GAC. | GGT.A | CC | .GC | G.G | G | C.CC | G. | GG | A.TCC | .ACC.GGA. | TC | T.AG | A. | TAA | .C | TG.A | TC.A |
* - not unique site.
# - sites are blocked by dam methylation. If you wish to digest the vector with these enzymes, you will need to transform the vector into a dam- host and make fresh DNA.
pPhi-Yellow-C is a mammalian expression vector encoding yellow fluorescent protein PhiYFP (see protein description). The vector allows generation of fusions to the PhiYFP C-terminus and expression of PhiYFP fusions or PhiYFP alone in eukaryotic (mammalian) cells.
PhiYFP codon usage is optimized for high expression in mammalian cells (humanized) [Haas et al., 1996]. To increase mRNA translation efficiency, Kozak consensus translation initiation site is generated upstream of the PhiYFP sequence [Kozak, 1987]. Multiple cloning site (MCS) is located between PhiYFP coding sequence and SV40 polyadenylation signal (SV40 polyA).
The vector backbone contains immediate early promoter of cytomegalovirus (PCMV IE) for protein expression, SV40 origin for replication in mammalian cells expressing SV40 T-antigen, pUC origin of replication for propagation in E. coli, and f1 origin for single-stranded DNA production. SV40 polyA direct proper processing of the 3'-end of the reporter mRNA.
SV40 early promoter (PSV40) provides neomycin resistance gene (Neor) expression to select stably transfected eukaryotic cells using G418. Bacterial promoter (P) provides kanamycin resistance gene expression (Kanr) in E. coli. Kanr/Neor gene is linked with herpes simplex virus (HSV) thymidine kinase (TK) polyadenylation signals.
Generation of PhiYFP-fusion proteins
A localization signal (or a gene of interest) should be cloned into MCS of the vector. It will be expressed as a fusion to the PhiYFP C-terminus when inserted in the same reading frame as PhiYFP and no intervening stop codons are present. PhiYFP-tagged fusions retain fluorescent properties of the native protein allowing fusion localization in vivo. Unmodified vector will express PhiYFP, when transfected into eukaryotic (mammalian) cells.
Note: The plasmid DNA was isolated from dam+-methylated E.coli. Therefore some restriction sites are blocked by methylation. If you wish to digest the vector using such sites you will need to transform the vector into a dam- host and make fresh DNA.
Expression in mammalian cells
pPhi-Yellow-C can be transfected into mammalian cells by any known transfection method. CMV promoter provides strong, constitutive expression of PhiYFP or its fusions in many cell types. If required, stable transformants can be selected using G418 [Gorman, 1985].
Propagation in E. coli
Suitable host strains for propagation in E. coli include DH5alpha, HB101, XL1-Blue, and other general purpose strains. Plasmid incompatibility group is pMB1/ColE1. The vector confers resistance to kanamycin (30 μg/ml) to E. coli hosts. Copy number in E. coli is about 500.
Location of features
PCMV IE: 1-589
Enhancer region: 59-465
TATA box: 554-560
Transcription start point: 583
PhiYFP-m
Kozak consensus translation initiation site: 606-616
Start codon (ATG): 613-615
Stop codon: 1384-1386
Last amino acid in PhiYFP-m: 1312-1314
MCS: 1315-1400
SV40 early mRNA polyadenylation signal
Polyadenylation signals: 1526-1531 & 1555-1560
mRNA 3' ends: 1564 & 1576
f1 single-strand DNA origin: 1623-2078
Eukaryotic promoter for expression of Kanr gene
-35 region: 2140-2145
-10 region: 2163-2168
Transcription start point: 2175
SV40 origin of replication: 2419-2554
SV40 early promoter
Enhancer (72-bp tandem repeats): 2252-2323 & 2324-2395
21-bp repeats: 2399-2419, 2420-2440 & 2442-2462
Early promoter element: 2475-2481
Major transcription start points: 2471, 2509, 2515 & 2520
Kanamycin/neomycin resistance gene
Neomycin phosphotransferase coding sequences:
Start codon (ATG): 2603-2605
Stop codon: 3395-3397
G->A mutation to remove Pst I site: 2785
C->A (Arg to Ser) mutation to remove BssH II site: 3131
Herpes simplex virus (HSV) thymidine kinase (TK) polyadenylation signal
Polyadenylation signals: 3633-3638 & 3646-3651
pUC plasmid replication origin: 3982-4625
Evrogen FP-related products are intended for research use only and covered by Evrogen Patents and/or Patent applications pending. By use of these products, you accept the terms and conditions of the applicable Limited Use Label License.
The CMV promoter is covered under U.S. Patents 5,168,062 and 5,385,839, and its use is permitted for research purposes only. Any other use of the CMV promoter requires a license from the University of Iowa Research Foundation, 214 Technology Innovation Center, Iowa City, IA 52242.
To the best of our knowledge, these products do not require a Material Safety Data Sheet. However, all the properties of these products (and, if applicable, each of their components) have not been thoroughly investigated. Therefore, we recommend that you use gloves and eye protection, and wear a laboratory coat when working with these products.
|
Copyright 2002-2008 Evrogen. All rights reserved. Evrogen JSC, 16/10 Miklukho-Maklaya str., Moscow, Russia, +7(495)4298020, e-mail:evrogen@evrogen.com |